Section 9
Sleep disorders

Alert

  • If a physician believes that a patient is likely to be at risk while driving because of a symptomatic sleep disorder and the patient refuses investigation by a sleep study or refuses appropriate treatment, that patient should not drive any class of motor vehicle.

9.1 Overview

Somnolence (sleepiness), with its associated reduction in vigilance, is an important contributor to driver error and motor vehicle crashes. Somnolence can be due to lifestyle issues, a sleep disorder, or both.

The 3rd edition of the International Classification of Sleep Disorders (American Academy of Sleep Medicine, 2014) outlines six categories of sleep disorders: insomnia, sleep-related breathing disorders, central disorders of hypersomnia, circadian rhythm sleep–wake disorders, parasomnias, and sleep-related movement disorders.

The recommendations that follow relate primarily to obstructive sleep apnea (OSA) and narcolepsy, the two sleep disorders for which there is a reasonably clear association between the disorder and the risk of a motor vehicle crash.

9.2 Assessment

Patients reporting excessive somnolence should be questioned in detail about the adequacy and regularity of their sleep–wake cycle, as attention to this may improve symptoms and reduce driving risk.

The following are some risk factors for sleep-related crashes:

  • holding multiple jobs
  • working a night shift
  • nighttime driving (between midnight and 6 am)
  • less than 6 hours of nighttime sleep
  • long-duration driving or driving after being awake for more than 15 hours
  • history of drowsy driving
  • daytime sleepiness
  • recent (within a year) at-fault motor vehicle crash.

Patients with various sleep disorders may also have one or more of these risk factors and, as a result, have varying levels of sleepiness. This may partly explain observed differences in the risk associated with operating a motor vehicle. The appropriateness of and need for medical intervention in the management of these disorders also varies.

Patients with excessive daytime somnolence should be questioned about and examined for the following risk factors for OSA:

  • chronic heavy snoring
  • nocturnal snorting and gasping
  • witnessed apnea
  • uncontrolled hypertension
  • significant cardiovascular disease
  • morning headaches
  • craniofacial abnormalities (e.g., macroglossia, retrognathia)
  • large neck size (≥ 43 cm [17 in])
  • obesity.

Men and patients older than 40 years of age are also at increased risk of OSA.

Patients with excessive somnolence and one or more risk factors for OSA, as well as those with persistent sleepiness and a history consistent with another sleep disorder (e.g., narcolepsy), should be considered for assessment in a sleep laboratory. When sleep laboratory resources are not available, portable monitoring devices can be used to confirm a diagnosis of OSA if monitoring is performed and interpreted according to published guidelines (Blackman et al., 2010).

9.3 Obstructive sleep apnea

OSA is characterized by repetitive upper airway obstruction during sleep, leading to recurrent episodes of hypoxemia and arousal from sleep and resulting in disturbed sleep patterns. The relative risk of motor vehicle crashes among patients with symptomatic OSA is about two to three times that of control groups (Mulgrew et al., 2008), with a risk for single and multiple crashes increasing with sleep apnea severity (Komada et al., 2009; Gottlieb et al., 2018). In severe cases of OSA, the risk of a motor vehicle crash may be increased as much as 10-fold (Arita et al., 2015). However, determining individual risk remains difficult because of individual variations in susceptibility to sleepiness, use of countermeasures, or driving avoidance.

Treatment of OSA with continuous positive airway pressure (CPAP) has been successful in reducing crash risk to control levels (George, 2001), particularly in patients with adequate treatment adherence (Karimi et al., 2015). Reassessment of patients using CPAP, with a compliance-metering device on the CPAP unit, should be done 1 to 2 months after diagnosis. The effectiveness of upper airway surgery is less clear (Haraldsson et al., 1995; Alkan et al., 2021), and patients treated by this method may require re-evaluation by sleep study.

Some patients with mild cases of OSA may be treated through behavioural modification (e.g., weight reduction [Ng et al., 2017], modification of sleeping position, elimination of alcohol and sedatives before sleep) or through the use of oral appliances (Phillips et al., 2013). These interventions may be sufficient, but patients require reassessment for efficacy of treatment before resumption of driving.

9.3.1 Driving recommendations for patients with OSA

The following recommendations should be made only when OSA has been diagnosed by physicians familiar with the interpretation of sleep studies and/or portable monitoring.

  • Regardless of apnea severity, all patients with OSA are subject to sleep schedule irregularities and subsequent sleepiness. Because impairment from OSA, sleep restriction, and irregular sleep schedules may be interactive, all patients should be advised about the dangers of driving when drowsy.
  • Patients with mild OSA without daytime somnolence who report no difficulty with driving are at low risk for motor vehicle crashes and should be safe to drive any type of motor vehicle.
  • Patients with OSA, documented by a sleep study, who are compliant with CPAP (defined as at least 4 hours per day of use on 70% of days over at least a 30-day period within the previous 90 days; Ayas et al., 2014) or who have had successful upper airway surgery or treatment with an oral appliance should be safe to drive any type of motor vehicle.
  • Patients with moderate to severe OSA, documented by a sleep study, who are not compliant with treatment and are considered at increased risk for motor vehicle crashes by the treating physician should not drive any type of motor vehicle.
  • Patients with a high apnea–hypopnea index, especially if associated with right heart failure or excessive daytime somnolence, should be considered at high risk for motor vehicle crashes.
  • Patients with OSA who are believed to be compliant with treatment but who are subsequently involved in a motor vehicle crash in which they were at fault should not drive for at least 1 month. During this period, their compliance with therapy must be reassessed. After the 1-month period, they may or may not drive depending on the results of the reassessment.
  • Recommendations for fitness to drive vary from one province or territory to another according to provincial and territorial driving safety rules.

9.4 Narcolepsy

Narcolepsy is characterized by recurrent lapses into sleep that are often sudden and irresistible and that typically last 10–15 minutes. Narcolepsy may be accompanied by cataplexy (sudden bilateral loss of muscle tone) during wakefulness, sleep paralysis (generalized inability to move or to speak during the sleep–wake transition), and vivid hallucinations at sleep onset.

Although there is a clear association between crash risk and narcolepsy, this association is not as well studied as that between crash risk and OSA.

Up to 40% of people with narcolepsy may report sleep-related motor vehicle crashes. Their risk for crashes is about four times that of control groups (Aldrich, 1989). Patients with cataplexy and sleep paralysis are believed to be at greatest risk for crashes, based on the relative unpredictability of these symptoms. In an online registry of patients with narcolepsy (with assessments completed every 6 months), almost 20% of patients reported a motor vehicle crash or near miss while driving (Ohayon et al., 2018). Younger age, higher score on the Epworth Sleepiness Scale, and presence of a psychiatric condition were associated with higher probability of a crash or a near miss. There is little information about the effect of treatment on risk for crashes.

9.4.1 Driving recommendations for patients with narcolepsy

  • Patients with a diagnosis of narcolepsy supported by a sleep study and a Multiple Sleep Latency Test and with uncontrolled episodes of cataplexy during the past 12 months (with or without treatment) should not drive any type of motor vehicle.
  • Patients with a diagnosis of narcolepsy supported by a sleep study and a Multiple Sleep Latency Test and with uncontrolled daytime sleep attacks or sleep paralysis in the past 12 months (with or without treatment) should not drive any type of motor vehicle.
  • Generally, patients with narcolepsy should not drive commercial vehicles, as long-distance driving can be difficult for these patients to manage without significant hypersomnolence. However, people with narcolepsy who are able to maintain a regular sleep–wake cycle may be able to drive commercial vehicles during the day, over short routes.

9.5 Other sleep disorders

Although short- and long-term insomnia may be the most common category of sleep disorder, there are no data linking increased motor vehicle crashes with insomnia.

Circadian rhythm sleep disorders, which are related to sleep loss from disruption of the daily sleep cycle, as seen with shift work or the jet lag experienced with transmeridian flights, are common and might easily be associated with a large number of crashes.

However, there are again no clear data linking them with crashes.

Accordingly, physicians can make only general recommendations about the hazards of drowsy driving due to these other sleep disorders.


References

Aldrich MS. Automobile accidents in patients with sleep disorders. Sleep. 1989;12(6):487-94.

Alkan U, Nachalon Y, Weiss P, Ritter A, Feinmesser R, Gilat H, et al. Effects of surgery for obstructive sleep apnea on cognitive function and driving performance. Sleep Breath. 2021;25(3):1593-600.

American Academy of Sleep Medicine. International classification of sleep disorders – third edition (ICSD-3). Darien (IL): The Academy; 2014.

Arita A, Sasanabe R, Hasegawa R, Nomura A, Hori R, Mano M, et al. Risk factors for automobile accidents caused by falling asleep while driving in obstructive sleep apnea syndrome. Sleep Breath. 2015;19(4):1229-34.

Ayas N, Skomro R, Blackman A, Curren K, Fitzpatrick M, Fleetham J, et al. Obstructive sleep apnea and driving: a Canadian Thoracic Society and Canadian Sleep Society position paper. Can Respir J. 2014;21(2):114-23.

Blackman A, McGregor C, Dales R, Driver HS, Dumov I, Fleming J, et al. Canadian Sleep Society/Canadian Thoracic Society position paper on the use of portable monitoring for the diagnosis of obstructive sleep apnea/hypopnea in adults. Can Respir J. 2010;17(5):229-32.

George CF. Reduction in motor vehicle collisions following treatment of sleep apnoea with nasal CPAP. Thorax. 2001;56(7):508-12.

Gottlieb DJ, Ellenbogen JM, Bianchi MT, Czeisler CA. Sleep deficiency and motor vehicle crash risk in the general population: a prospective cohort study. BMC Med. 2018;16(1):44.

Haraldsson PO, Carenfelt C, Lysdahl M, Tingvall C. Does uvulopalatopharyngoplasty inhibit automobile accidents? Laryngoscope. 1995;105(6):657-61.

Karimi M, Hedner J, Habel H, Nerman O, Grote L. Sleep apnea-related risk of motor vehicle accidents is reduced by continuous positive airway pressure: Swedish Traffic Accident Registry data. Sleep. 2015;38(3):341-9.

Komada Y, Nishida Y, Namba K, Abe T, Tsuiki S, Inoue Y. Elevated risk of motor vehicle accident for male drivers with obstructive sleep apnea syndrome in the Tokyo metropolitan area. Tohoku J Exp Med. 2009;219(1):11-6.

Mulgrew AT, Nasvadi G, Butt A, Cheema R, Fox N, Fleetham JA, et al. Risk and severity of motor vehicle crashes in patients with obstructive sleep apnoea/ hypopnoea. Thorax. 2008;63(6):536-41.

Ng WL, Stevenson CE, Wong E, Tanamas S, Boelsen-Robinson T, Shaw JE, et al. Does intentional weight loss improve daytime sleepiness? A systematic review and meta-analysis. Obes Rev. 2017;18(4):460-75.

Ohayon M, Pasta DJ, Cisternas MG, Williams M, Carls G, Black J, et al. Injuries, motor vehicle accidents, and near misses in narcolepsy: results from the nexus narcolepsy registry [abstract 0629]. Sleep. 2018;41(Suppl 1):A234.

Phillips CL, Grunstein RR, Darendeliler MA, Mihailidou AS, Srinivasan VK, Yee BJ, et al. Health outcomes of continuous positive airway pressure versus oral appliance treatment for obstructive sleep apnea: a randomized controlled trial. Am J Respir Crit Care Med. 2013;187(8):879-87.


Other resources

Canadian Council of Motor Transport Administrators. National Safety Code. Standard 6. Determining driver fitness in Canada. Part 1: A model for the administration of driver fitness programs. Part 2: CCMTA medical standards for drivers. Ottawa (ON): The Council; 2021. Available: https://ccmta.ca/web/default/files/PDF/National%20Safety%20Code%20Stand… (accessed 2022 July 4).

Carr DB, Schwartzberg JG, Manning L, Sempek J. Physician's guide to assessing and counseling older drivers. 2nd ed. Chicago (IL): American Medical Association; National Highway Traffic Safety Administration (US); 2010. Available: https://ami.group.uq.edu.au/files/155/physicians_guide_assessing_older_adult_drivers.pdf (accessed 2022 Aug. 10).

Drake C, Roehrs T, Breslau N, Johnson E, Jefferson C, Scofield H, et al. The 10-year risk of verified motor vehicle crashes in relation to physiologic sleepiness. Sleep. 2010;33(6):745-52.

Driver and Vehicle Licensing Agency (UK). Assessing fitness to drive: a guide for medical professionals. Swansea (UK): The Agency; 2016 [updated 2022 June]. Available: https://www.gov.uk/government/publications/assessing-fitness-to-drive-a-guide-for-medical-professionals (accessed 2022 Aug. 17).

Gurubhagavatula I, Nkwuo JE, Maislin G, Pack AI. Estimated cost of crashes in commercial drivers supports screening and treatment of obstructive sleep apnea. Accid Anal Prev. 2008;40(1):104-15.

Iverson DJ, Gronseth GS, Reger MA, Classen S, Dubinsky RM, Rizzo M. Practice parameter update: evaluation and management of driving risk in dementia: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2010;74(16):1316-24.

National Highway Traffic Safety Administration. Driver fitness medical guidelines. Washington (DC): The Administration; 2009. Available: https://www. nhtsa.gov/sites/nhtsa.gov/files/811210.pdf (accessed 2022 July 7).

Pack AI, Maislin G, Staley B, Pack FM, Rogers WC, George CF, et al. Impaired performance in commercial drivers: role of sleep apnea and short sleep duration. Am J Respir Crit Care Med. 2006;174(4):446-54.

Road Safety Authority (RSA), National Office for Traffic Medicine. Sláinte agus Tiomáint: Medical fitness to drive guidelines (group 1 and 2 drivers). 9th ed. Dublin, Ireland: Royal College of Physicians of Ireland/RSA; 2020. Available: https://www.ndls.ie/images/PDF_Documents/Slainte_agus_Tiomaint_ Medical_Fitness_to_Drive_Guidelines.pdf (accessed 2022 Aug. 17).

Robb G, Sultana S, Ameratunga S, Jackson R. A systematic review of epidemiological studies investigating risk factors for work-related road traffic crashes and injuries. Inj Prev. 2008;14(1):51-8.

Tregear S, Reston J, Schoelles K, Phillips B. Obstructive sleep apnea and risk of motor vehicle crash: systematic review and meta-analysis. J Clin Sleep Med. 2009;5(6):573-81.

Tregear S, Reston J, Schoelles K, Phillips B. Continuous positive airway pressure reduces risk of motor vehicle crash among drivers with obstructive sleep apnea: systematic review and meta-analysis. Sleep. 2010;33(10):1373-80.